Compliance Certificate By Practising Company Secretary Under Regulation 40(9) Of SEBI(LODR) Regulations, 2015
Certificate under Reg 40(9) of SEBI(LODR) Regulations, 2015 for the half yearly ended March 31, 201725-04-2017
25-04-2017
Statement Of Investor Complaints For The Quarter Ended March 31, 2017
Statement of Investor Complaints during the three months from January 01, 2017 to March 31, 2017, pursuant to Regulation 13(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.20-04-2017
Shareholding for the Period Ended March 31, 2017
Orchid Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click here19-04-2017
Credit Rating
Intimation of Revision in ratings under SEBI(Listing obligations and Disclosure Requirements), Regulations, 201517-04-2017
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for06-04-2017
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for R Vijayalakshmi23-03-2017
The Hindu Auto Expo on March 18, 19
The second edition of The Hindu Auto Expo 2017 will be held on March 18 and 19 at White Orchid, adjacent to Manyata Embassy Business Park, on the Hebbal-K R Puram Ring Road, Nagavara. The two-day...16-03-2017
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for R Vijayalakshmi16-03-2017